Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial
- 1 October 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9240), 1470-1474
- https://doi.org/10.1016/s0140-6736(00)02870-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency VirusAnnals of Internal Medicine, 1999
- HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-upTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Two-year follow-up of persons with HIV-1− and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West AfricaAIDS, 1995
- Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.American Journal of Respiratory and Critical Care Medicine, 1994
- A rapid manual method for CD4+ T-cell quantitation for use in developing countriesAIDS, 1993
- Increased recurrence of tuberculosis in HIV-1-infected patients in KenyaThe Lancet, 1993
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- Increased Mortality and Tuberculosis Treatment Failure Rate among Human Immunodeficiency Virus (HIV) Seropositive Compared with HIV Seronegative Patients with Pulmonary Tuberculosis Treated with “Standard” Chemotherapy in Kinshasa, ZaireAmerican Review of Respiratory Disease, 1991
- Diagnostic Standards and Classification of TuberculosisAmerican Review of Respiratory Disease, 1990
- Treatment and Prophylaxis ofIsospora belliInfection in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1989